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ABSTRACT 
Objective: The objective of this study was to formulate and evaluate the Curcumin (CUR) encapsulated sodium alginate (SA)/badam gum 
(BG)/kaolin (KA) microbeads for controlled drug release studies. 
Methods: The fabricated microbeads were characterized by fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry 
(DSC), thermogravimetric analysis (TGA), X-ray diffraction (X-RD), and scanning electron microscopy (SEM). Dynamic swelling studies and in 
vitro release kinetics were performed in simulated intestinal fluid (pH 7.4) and simulated gastric fluid (pH 1.2) at 37 °C.  
Results: FTIR confirms the formation of microbeads. DSC studies confirm the polymorphism of CUR in drug loaded microbeads which indicate the 
molecular level dispersion of the drug in the microbeads. SEM studies confirmed the microbeads are spherical in shape with wrinkled and rough 
surfaces. XRD studies reveal the molecular dispersion of CUR and the presence of KA in the developed microbeads. In vitro release studies and 
swelling studies depend on the pH of test media, which might be suitable for intestinal drug delivery. The % of drug release values fit into the 
Korsmeyer-Peppas equation and n values are obtained in the range of 0.577-0.664, which indicates that the developed microbeads follow the non-
Fickian diffusion drug release mechanism. 
Conclusion: The results concluded that the CUR encapsulated microbeads are potentially good carriers for controlled drug release studies.  
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INTRODUCTION 
A drug delivery system is designed to allow a therapeutic agent to be 
introduced into the biological organism and to enhance its 
effectiveness and safety by controlling the release rate, time and 
place of drug release in the body [1]. The development of effective 
therapeutic drug delivery systems is essential for medicine and 
health care in order to increase the safety, efficacy, and 
bioavailability of the drugs. Over the past few decades, polymeric 
matrices are used in many pharmaceutical applications because it 
offers various advantages like efficiency in administering the drug to 
the specific target at a proper time thereby improving the overall 
therapeutic response of a dosage form, high water absorption 
tendency and capable of swelling under physiological conditions [2-
4]. Hence, the utility of polymeric materials is increasing day by day 
as the pharmaceutical industry expands globally. Now-a-days, 
Polymeric interpenetrating polymer network hydrogels have been 
widely used in biomedical applications such as drug delivery and 
tissue engineering due to their water intake capacity, 
biocompatibility, and biodegradability [5]. However, IPN hydrogels 
dosage forms have few drawbacks like uncontrolled swelling and 
release rate, which leads to several side effects. The polymeric 
networks are crosslinked with several crosslinking agents, coated 
with other polymers and intercalated with clay minerals, which 
control the release and swelling rates. Presence of clay minerals in 
polymeric matrices, minimizing side effects and maintaining the 
effective drug concentration in plasma over a period of time [6]. 
From the last few decades, clay minerals are used in solid and 
semisolid pharmaceutical preparations for topical and oral 
administration, as well as cosmetic formulations [7, 8]. Kaolin is a 
hydrated two-dimensional (2D) aluminosilicate clay mineral, used as 
active ingredients due to their uninjured bioactivity and therapeutic 
effects. They are developed as a hemostatic agent, dermatological 
protector, anti-inflammatory agent and pelotherapy, or oral 
products as a gastrointestinal protector, antimicrobial, detoxifying 
or anti-diarrheal agent in health-care topical items [9-13]. Moreover, 
kaolin and its modified derivatives have recently been considered a 
promising material in many areas of biomedical research, such as 
drug, protein and gene delivery, based on the high capacity of 
interaction with organic and biochemical molecules, bio-adhesion 
and cellular uptake. It can acts as an active ingredient or as adjuvant 
component in pharmaceutical dosage forms by controlling the 
efficiency and consistency in the dosage formulations and improving 
the drug bioavailability [14-16]. 
Sodium alginate (SA) is a linear polymer that has D-mannuronic acid 
and L-guluronic acid residues in the polymer chain, obtained from 
brown seaweed [17]. SA is one of the most adaptable, versatile 
polymers, widely used in the food, cosmetic, and pharmaceutical 
industries because of its properties like biocompatible, 
biodegradable, inherent hydrophilicity, non-toxic and good 
potentiality in drug delivery applications [18]. In recent decades, it is 
used as a potential tool for developing a different type of controlled, 
sustained, and targeted drug delivery systems. In addition, it is also 
used in the semisolid formulation and wound dressing applications 
[19]. Badam gum (BG) is a natural gum obtained from Terminalia 
catappa LINN, belongs to the family Combretaceae [20]. It can be 
used in pharmaceutical applications because of its abundant 
availability, reliability, efficiency, eco-friendly, and economical 
features. Previously Srikanth et al. [21] has reported that BG was 
used in controlled drug delivery systems as a retarding polymer for 
a highly soluble drug like propranolol HCl. 
Curcumin is a natural bioactive compound derived from the Curcuma 
longa species and possesses a wide range of pharmacological 
properties such as antifungal, antiviral, antibacterial, anti-
inflammatory, anti-malarial, antioxidant, anti-mutagenic agent, wound 
healing properties as well as it enhances anti-tumour activity against 
different types of cancer cells [22-24]. However, due to its poor water-
solubility, short life and low bioavailability, the therapeutic use of CUR 
are limited [25, 26]. Generally, simple ionotropic gelation techniques 
are used to encapsulate hydrophilic drugs in hydrogel beads, but 
because of its poor water solubility, this technique gives low CUR 
encapsulation efficiency. Thus, in the present study, KA clay material 
was used to increase the drug encapsulation efficiency of CUR, the 
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muco-adhesiveness of KA clay material facilitates the intercalation of 
drug molecules which in turn increases the encapsulation and 
bioavailability of CUR. 
In the present research work, we focussed on the fabrication of nano 
KA clay intercalated with SA/BG microbeads. The presence of KA in 
the polymer networks increases the bioavailability of CUR and also 
controls the release rate of CUR. The developed microbeads were 
characterized by different techniques such as FTIR, DSC, TGA, X-RD, 
and SEM. The swelling studies and in vitro drug release kinetics were 
performed in both simulated intestinal fluid and simulated gastric 
fluid at 37 °C and the results are presented here. 
MATERIALS AND METHODS  
Materials 
Badam gum and Kaolin were purchased from Sigma Aldrich (USA). 
Sodium alginate and calcium chloride were purchased from Sd. Fine 
chemicals, Mumbai, India. Curcumin was purchased from Loba 
Chemicals, Mumbai, India. Double distilled water was used 
throughout the study. 
Methods 
Preparation of SA/BG/KA microbeads 
A Simple gelation method was used to fabricate drug-loaded SA/BG/KA 
microbeads [7]. Briefly, different amounts of SA and BG (table 1) were 
dissolved in water overnight under constant stirring. Different blends of 
these solutions were prepared by mixing varying amounts of SA and BG 
(as per given in table 1) and stirred well until to obtain a complete 
homogeneous solution. To this blend solution, different amounts of CUR 
and KA (table 1) were added and stirred well up to the formation of a 
homogeneous mixture. Then the blend mixture was added drop wise 
into 5% CaCl2
Characterizations methods 
 solution through a syringe (1 mm diameter) under 
constant stirring. The obtained microbeads were collected by 
decantation, washed three times with double distilled water to remove 
the drug attached on the bead surface, and finally were dried in air 
overnight at room temperature. A schematic diagram (Scheme 1) for the 
synthesis of CUR encapsulated SA/BG/KA microbeads was given below 
Intercalation kinetics 
The intercalation time of CUR with KA was estimated by the 
following procedure. Briefly, 50 mg of CUR and 100 mg of KA was 
weighed and dissolved in 20 ml of double distilled water with 
continuous stirring at 37 °C. At regular intervals of time, the drug 
solution was filtered and concentration of CUR was assayed using 
UV spectrophotometer at fixed λmax value of 470.00 nm. 
Fourier transform infrared (FTIR) spectral analysis 
To find out the type of bonding as well as the ionic interactions 
between polymers, KA and CUR fourier transform infrared 
spectroscopy spectra were performed and the developed 
microbeads were recorded with FTIR spectrophotometer (model 
Bomem MB-3000, with Horizon MBTM FTIR software) in the 




Scheme 1: Schematic procedure for the preparation of CUR encapsulated SA/BG/KA microbeads 
 
Table 1: Formulation and composition of all samples 
Formulation code SA (mg) BG (mg) Water (ml) KA (mg) Drug (mg) 
SB1 320 80 20 100 100 
SB2 280 120 20 100 100 
SB3 240 160 20 100 100 
SB4 240 160 20 200 100 
SB5 240 160 20 300 100 
SB6 240 160 20 100 150 
SB7 240 160 20 100 200 
Placebo 240 160 20 00 000 
  
Thermal analysis 
To investigate the molecular dispersion of CUR and thermal stability 
of KA intercalated SA/BG/CUR loaded microbeads, differential 
scanning calorimetry (DSC) and Thermogravimetric analysis (TGA) 
were performed by heating the sample at a heating rate of 10 °C/min 
under nitrogen atmosphere from 40 to 600 °C.  
X-ray diffraction (XRD)  
The X-ray diffraction of CUR, KA, placebo microbeads, and drug 
loaded microbeads were performed by a wide angle X-ray scattering 
diffractometer (Panalytical X-ray Diffractometer, model-X’pert Pro) 
with CuKα radiation (λ= 1.54060) at a scanning rate of 10 °/min to 
determine the crystallinity. 
Scanning electron microscopy (SEM) 
The morphological characterization of microbeads was observed by 
using SEM (JOEL MODEL JSM 840A) with an accelerated voltage of 
20 kV. 
Encapsulation efficiency 
The encapsulation efficiency of drug loaded microbeads was 
estimated by the following procedure. Weight exactly 20 mg of 
microbeads and placed into 100 ml of phosphate buffer solution (pH 
7.4 containing 5 % absolute ethyl alcohol) for 24 h. Afterward, the 
solution was stirred and placed sonication for 5 min to ensure the 
complete extraction of CUR from the microbeads. Supernatants were 
filtered and analyzed by ultraviolet (UV) spectrophotometer 
(LabIndia, Mumbai, India) at the λmax
% EE = Wt
Wi
 x 100 
 of 470.00 nm with placebo 
microbeads were used as a blank correction. The percentage of 
encapsulation efficiency was determined by the following formula. 
Where Wt is total amount of CUR in the microbeads and Wi
Swelling measurements 
 is total 
amount of CUR initially added during the preparation 
The swelling behaviour of different formulations was determined 
gravimetrically in simulated intestinal fluid (pH 7.4) and simulated 
gastric fluid (pH 1.2) at 37 °C. The % of equilibrium swelling degree 
was calculated using the following equation:  
% swelling degree = Ww− Wd
Wd
x 100 
Where Ww is the weight of the wet microbeads and Wd the weight of 
the dried microbeads. 
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In vitro drug release studies 
In vitro drug release studies of developed microbeads were carried out 
in simulated intestinal fluid (pH 7.4) and simulated gastric fluid (pH 
1.2) at 37 °C using a dissolution tester (Lab India, Mumbai, India). 
Briefly, 100 mg of drug loaded microbeads were taken in a dialysis 
bags and placed in 900 ml of phosphate buffer solution (PBS) at a 
rotation speed of 50 rpm. At regular intervals of time, 5 ml aliquot 
samples were withdrawn, and analyzed using UV spectrophotometer 
at fixed λmax
Drug release kinetics 
 value of 470.00 nm, at the same time equal amount of PBS 
sample was added into the system to maintain sink condition. 
The drug release kinetics was analyzed by fitting the data into 
kinetic models, which include zeroth, first order, Higuchi and 
Korsmeyer-Peppas [27-30]. Based on the goodness of data fit, the 
most suitable model was also determined [31]. 
RESULTS AND DISCUSSION 
Intercalation kinetics 
To investigate the intercalation time of CUR with KA intercalation 
kinetics were performed and the result was displayed in fig. 1. The 
result reveals that 14.59 % of CUR intercalated with electrostatically 
within 90 min and remained constant up to 360 min. Therefore in 
the present study, we should maintain 90 min time for interaction 
between CUR and KA to prevent partial interaction. 
 
 
Fig. 1: Effect of time for intercalation of CUR with KA 
 
FTIR spectral analysis 
To find out the type of bonding as well as the ionic interactions 
between polymer, CUR and KA FTIR analysis were performed and the 
results are displayed in fig. 2. The FTIR spectra of CUR show 
characteristic bands at 3496 cm-1and 2923 cm-1, which corresponds to 
phenolic O–H stretching and aromatic C–H stretching vibrations 
respectively, a band at 1513 cm-1 corresponds to mixed (C=O) and 
(C=C) vibration, a band at 1272 cm-1 is assigned to Ar-O stretching 
vibrations [25]. The absorption bands of KA which were found at 
3688, 3625, 3456 and 2360 cm-1 can be associated with the O–H, 
Si/Al–OH, H–O–H and C–H stretching frequencies respectively, the 
absorption bands at 1126 and 902 cm-1 corresponds to Si–O–Si 
stretching band [32]. The FTIR spectra of SA show bands at 3417, 
1596 and 1383 cm-1 may be attributed to symmetric and asymmetric 
stretching frequencies of hydroxyl (O–H), carbonyl (C=O) and 
carboxylate (COO-) groups respectively. On comparing the FTIR 
spectra of placebo microbeads and drug loaded microbeads (SB7), a 
new band at 1575 cm-1 was observed, which similar to that of Ar-O 
stretching vibration of CUR, suggesting that drug was present in SB7. 
And also the band at 1594 cm-1in placebo microbeads was shifted to 
1588 cm-1in drug loaded SB7 microbeads, which confirmed that the 
drug interacts with the polymer matrix. In case of SB7 the O–H 
stretching frequency was decreased due to the intermolecular 
hydrogen bonding between silanol groups on the clay surface and the 
hydroxyl or carboxyl groups of polymer molecules and also a new 
band appears at 911 cm-1
 
, which confirmed that the KA intercalates 
with active sites of polymer matrices and drug molecules [33]. 
 
Fig. 2: FTIR spectra of SA, BG, KA, CUR, placebo microbeads, and 
drug loaded microbeads (SB7) 
 
Thermal analysis 
To investigate the crystalline nature of CUR in the polymer matrix as 
well as the interaction of KA with polymer matrix DSC analysis was 
performed and the results were displayed in fig. 3. The DSC of KA 
showed peaks at 272 and 496 °C, whereas SB7 microbeads also 
showed similar peaks like that of KA at 321 and 481 °C but a slight 
variation was observed, which confirmed that the interaction takes 
place between active sites of the polymer matrix and KA. The DSC 
curve of CUR showed a sharp peak at 189 °C, whereas such a peak 
was not observed in SB7 microbeads, suggesting that the CUR has 
molecularly dispersed in the polymer networks. 
To find out the thermal stability of microbeads, TGA analysis was 
performed and the results are shown in fig. 4. The TGA curve of SA 
showed three weight loss steps, the first weight loss step with 
weight loss of 17 % was observed in the region of 40–118 °C due to 
the dehydration process. The next two weight loss steps were found 
in the region of 123–215 and 227–600 °C with weight loss of 4 and 
48 % respectively, which is due to the formation of sodium 
carbonate residue [34]. The thermal decomposition BG occurs in two 
steps, the first weight loss step was found in the region of 40–196 °C 
with a weight loss of 18%, which is due to dehydration of adsorbed 
water molecules on the surface. The next weight loss step was found 
in the region of 201–600 °C with a weight loss of 55%, corresponds 
to the decomposition of BG polymer. The TGA curve of CUR showed 
that the CUR could remain stable up to 168 °C, following the mass 
loss and maximum at 391 °C due to the complete degradation of CUR 
[35]. The thermal decomposition of KA showed two weight loss 
steps, the first step was observed in the region of 40–256 °C with a 
loss of 6 % followed by weight loss of 13% in the region of 259–600 
°C, corresponds to the loss of structural water molecules [7]. The 
TGA curve of placebo microbeads showed three consecutive weight 
loss steps, the first weight loss step with a loss of 24 % was found in 
between 40-192 °C, which corresponds to dehydration of adsorbed 
water molecules. The second step was observed in the region of 197-
305 °C with a loss of 34% followed by the weight loss of 8% was 
observed in the region of 311–600 °C, due to the decomposition of 
the polymer network. Similarly, CUR loaded microbeads (SB7) also 
showed three weight loss steps, the first weight loss step was found 
in the region of 40–185 °C with a loss of 15%, that is ascribed to the 
dehydration of water molecules adsorbed on the surface of 
microbeads. The next two steps were observed in the region of 191–
308 °C and 311–600 °C with a loss of 19 and 14 %, which 
corresponds to the degradation of the polymer matrix. The TGA 
results suggest that the developed microbeads show an overall 
improvement in thermal stability. 
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Fig. 3: DSC curves of SA, BG, KA, CUR, Placebo and drug loaded microbeads (SB7) 
 
 
Fig. 4: TGA curves of SA, BG, KA, CUR, Placebo and drug loaded microbeads (SB7) 
 
X-RD analysis 
To examine the molecular dispersion of CUR and the presence of KA in 
the developed microbeads X-RD analysis was performed and the results 
are displayed in fig. 5. The diffractogram of CUR shows characteristic 
peaks in the 2θ region of 12-28° because of its crystallinity. These peaks 
are not observed in the polymer matrix of SB-7 microbeads, which 
indicates that CUR has molecularly dispersed in the polymeric 
microbeads. Kaolinite and quartz phases were observed in the kaolin 
clay. The diffractogram of KA shows characteristic peaks at 11.95°, 
18.34°, 19.97° and 24.84° which indicate the presence of kaolinite. A 
small reflection at 26.6° was observed in the diffractogram of KA, which 
indicates the presence of traces of quartz. These results are in good 
agreement with Khan et al. [36] who found the same results from the 
pyrolysis kinetics of the conversion of Malaysian kaolin to metakaolin. 
The diffractogram of SB-7 microbeads also showed similar peaks to that 
of KA with slight variations, suggesting that the KA has successfully 
loaded in the microbeads. 
SEM analysis 
The topographical images of developed microbeads were found out 
using SEM analysis and the images are presented in fig. 6. The 
microbeads are spherical in shape with wrinkled and rough surfaces. 
It is interesting that the surface of SB-7 has high roughness compare 
to placebo microbeads, which indicates the presence of KA platelets 
on the outer surface of microbeads. A similar observation was 
reported by Reddy et al. [7] from the development of sodium 
alginate/gelatin microbeads-intercalated with kaolin nanoclay. The 
average diameter of the microbeads obtained from the SEM was in 
the range of 700-1300 μm. 
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Fig. 5: XRD patterns of CUR, placebo, KA and SB-7 
 
 
Fig. 6: The topographical images of drug loaded microbeads (SB7) (a and b) and placebo microbeads (c and d) 
 
 
Fig. 7: EDS spectra of placebo and SB-7 microbeads 
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Energy-dispersive X-ray spectra (EDS) analysis 
To find out the elements present in the developed microbeads 
energy-dispersive X-ray spectra (EDS) analysis were performed and 
the results are presented in fig. 7. The EDS spectra of placebo 
microbeads showed C, O, Al, Cl and Ca elemental peaks. Whereas in 
the case of KA loaded microbeads (SB-7) showed similar elements 
that of placebo microbeads along with that new elemental peaks 
such as Na, Si and Al were observed with high intensity, which 
confirms the presence of KA in the SB-7 microbeads. 
Swelling measurements 
Swelling degree plays a key role in the controlled release of drugs in 
polymeric drug delivery systems. In the present study swelling 
experiments were carried out at pH 1.2 and 7.4 at 37 °C and the 
results were displayed in fig. 8. From the results, it was clearly 
observed that a higher swelling degree was observed at pH 7.4 than 
at pH 1.2, this may be due to at pH 7.4, carboxylic groups show fewer 
interactions with buffer media and thus the network becomes 
looser, making it easier for the entrapped drug molecules to leach 
out of the polymer network. A similar observation was reported by 
Reddy et al. [37] from their glycopyrrolate release studies of sodium 
alginate/poly (vinylpyrrolidone-co-vinyl acetate) microbeads. The 
developed microbeads are therefore good promising carriers for 
delivering drug molecules to the intestine and preventing the gastric 
release of drugs. 
Encapsulation efficiency (% EE) 
The percentages of encapsulation efficiency (% EE) of CUR loaded 
microbeads are displayed in table 2. The % EE values lies between 
45% to 53%. This indicates the %EE dependence on formulation 
parameters which include % drug loading, polymer blend 
composition and amount of KA. The % EE increases with the 
increase of drug loading in the polymer matrix. The % EE increases 
with an increase of SA in the polymer matrix this is due to curcumin 
alginate interactions (Hydrophilic and Hydrophobic). A similar 
observation was observed by Govindaraju et al. [38] from their 
curcumin encapsulated in alginate-polysorbate 80 nanoparticles. 
The % EE increases with the increase of KA content in the polymer 
matrix, which is due to the availability of large basal space, good 
absorption capacity and availability of free–OH groups of KA. The 
presence of–OH groups develops a hydrogen bonding between CUR 
and KA, consequently % EE increases. 
 
 
Fig. 8: Swelling studies of all profiles at pH 7.4 and pH 1.2 at 37 °C 
 
Table 2: Encapsulation efficiency (% EE) of all samples 
S. No. Formulation code %EE 
1 SB1 48±1.6 
2 SB2 47±1.2 
3 SB3 45±0.8 
4 SB4 51±1.3 
5 SB5 53±1.1 
6 SB6 47±1.5 
7 SB7 48±2.1 
(Results are expressed as mean±SD, n=3) 
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In vitro drug release studies 
The in vitro release studies of all profiles were investigated under 
both pH 1.2 and pH 7.4 at 37 °C and the results are shown in fig. 9 to 
12. The findings show that the percentage of CUR release is higher at 
pH 7.4 than at pH 1.2, which is attributed to at pH 7.4 the 
carboxylate group has fewer interactions with the buffer media, thus 
the network becomes slacker, hence the trapped drug molecules are 
quickly leached out of the polymer matrix. It has been observed that 
similar to swelling behaviour, in vitro release rate also shows the 
same type of results. In vitro drug release studies for all profiles at 
pH 7.4 were discussed in terms of polymer blend variation, drug 




Fig. 9: In vitro release profiles of CUR microbeads in PBS pH 1.2 at 37 °C 
 
Effect of polymer content 
The effect of the polymer blend matrix on drug release profiles was 
studied at the constant loading of the drug (100 mg) and KA (100 mg). 
The drug release profiles of SB1, SB2 and SB3 are 82, 80 and 75 % 
respectively are displayed in fig. 10. The percentage of CUR release was 
increased with the increasing amount of SA, this is due to the more 
hydrophilic nature of SA. These results are in good agreement with Rao 
et al. [39] who observed similar results from their drug release studies of 
sodium alginate–locust bean gum IPN hydrogel beads. 
 
 
Fig. 10: Effect of polymer blend composition on % of CUR release in PBS pH-7.4 at 37 °C 
 
Effect of KA content 
To find out the effect of KA on in vitro release profiles were 
studied at constant polymer matrix and drug content. The release 
profiles of SB3, SB4 and SB5 are 75, 71 and 66 % respectively are 
shown in fig. 11. The release rate of CUR was decreased with 
increasing the KA content, because the intercalated drug 
molecules cannot be exchanged completely with phosphate ions in 
the buffer solution during the ion exchange process, which results 
the incomplete release process, consequently release rate 
decreases. 
Effect of drug content 
The effect of drug content on in vitro release profiles was studied at the 
constant polymer and KA content. The release rate of B3 (100 mg), 
SB6 (150 mg) and SB7 (200 mg) are 75, 77 and 80% respectively are 
displayed in fig. 12. The results suggesting that as the amount of drug 
content increases the release rate also increases. Hence, the release 
rate is higher for those formulations having a higher amount of drug 
and vice-versa. These results are good agreement with Madhavi et al. 
[40] who found that the drug release rate increases with the increase 
of drug concentration from their drug release studies of simvastin. 
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Fig. 11: Effect of KA content on % of CUR release in PBS pH-7.4 at 37 °C 
 
 
Fig. 12: Effect of drug content on % of CUR release in PBS pH-7.4 at 37 °C 
 
 
Fig. 13: Evaluation of drug release models in PBS 7.4 at 37 °C (A) Higuchi model (B) first order and (C) zero order 
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Table 3: Release kinetics parameters at pH-7.4 and encapsulation efficiency (% EE) of all samples 
Formulation code Korsmeyer peppas Higuchi First Zero 
r n 2 r K2 rH K2 r1 K2 0 
SB1 0.973 0.577 0.937 18.380 0.936 0.0780 0.768 3.201 
SB2 0.975 0.626 0.965 18.508 0.941 0.0732 0.842 3.299 
SB3 0.985 0.650 0.970 17.831 0.947 0.0642 0.856 3.195 
SB4 0.985 0.664 0.977 17.280 0.945 0.0588 0.888 3.138 
SB5 0.991 0.632 0.979 16.037 0.956 0.0511 0.929 2.961 
SB6 0.964 0.623 0.962 17.935 0.921 0.0680 0.836 3.192 
SB7 0.961 0.616 0.944 18.225 0.929 0.0731 0.813 3.201 
 
Drug release kinetics 
The cumulative drug release data of all profiles were fitted into 
various mathematical models such as zero order, first order and 
Higuchi. The correlation coefficient and rate constant values of all 
models are shown in table 3 and fig. 13. The correlation coefficient 
values of CUR loaded microbeads were close to the Higuchi model. 
According to the Higuchi model, the release of drug from the 
microbeads involves the penetration of liquid into the matrix and 
dissolves the drug, which then diffuses the drug through pores or 
intestinal channels into the exterior liquid. However, this type of 
phenomenon is observed in the hydrophilic matrix system. 
Therefore the drug release rate of CUR loaded microbeads shows the 
phenomenon of swelling and erosion of the polymer simultaneously. 
To understand the drug release mechanism, the in vitro release data 




Where, Mt is the cumulative release of CUR at time t, Mα is the total 
amount of CUR in the matrix, k is a characteristic release constant of 
the drug-polymer system and n is the release exponent indicating the 
type of drug release mechanism. The results n and k are listed in table 
2. For spherical drug carriers, if n<0.43, the drug diffuses from the 
polymer matrix according to Fickian diffusion; if 0.43<n<0.85, 
anomalous or non-Fickian type drug diffusion occurs; if n = 0.85, Case-
II kinetics is operative; if n>0.85, the mode of drug release follows the 
super Case-II diffusion. In the present data n values are obtained in the 
range of 0.577-0.664 indicates non-Fickian type of diffusion process. 
CONCLUSION 
In the present work, KA intercalated SA/BG microbeads were 
fabricated using a simple ionotropic gelation method for the controlled 
release of CUR. FTIR confirmed the interaction between CUR 
molecules and the polymer network. TGA, DSC and XRD studies 
confirmed the chemical stability and molecular dispersion of CUR. SEM 
studies reveal that the developed microbeads are spherical and also 
the outer surface of SB-7 microbeads showed high roughness which 
confirms the presence of KA platelets in the developed microbeads. 
The results of EDS spectra confirm the presence of KA in the polymeric 
microbeads. At pH 7.4 higher swelling degree and release rate were 
observed, suggesting that the developed microbeads might be suitable 
for intestinal drug delivery. The in vitro results were fitted into Peppas 
equation and the results showed that the drug mechanism followed a 
non-Fickian type of diffusion process Based on the results, it was 
suggesting that Kaolin intercalated microbeads were potentially good 
carriers for the controlled release of CUR. 
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